Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors
Christopher Heeschen, … , Stefanie Dimmeler, John P. Cooke
Christopher Heeschen, … , Stefanie Dimmeler, John P. Cooke
Published August 15, 2002
Citation Information: J Clin Invest. 2002;110(4):527-536. https://doi.org/10.1172/JCI14676.
View: Text | PDF
Article Vascular biology

A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors

  • Text
  • PDF
Abstract

Research Article

Authors

Christopher Heeschen, Michael Weis, Alexandra Aicher, Stefanie Dimmeler, John P. Cooke

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Effect of nAChR inhibition on angiogenesis in vitro. (a) Seeding of ECs ...
Effect of nAChR inhibition on angiogenesis in vitro. (a) Seeding of ECs on Matrigel resulted in capillary network formation within 48 hours. (b–d) Mecamylamine dose-dependently inhibited network formation: 1 nM (b), 100 nM (c), and 1 μM (d). (e) If mecamylamine (1 μM) was removed after 36 hours, the effect of mecamylamine on in vitro angiogenesis was reversible and endothelial networks had formed by 72 hours. Representative microscopic pictures are shown. (f) This effect of mecamylamine on network formation was mimicked by the α7-nAChR inhibitor α-bungarotoxin (1 nM). (g) Other selective nAChR antagonists did not result in a significant reduction of network formation. Results are shown as box plots displaying 25th and 75th percentiles as boxes and 5th and 95th percentiles as thin lines (n = 4; *P < 0.001 vs. control. Data are expressed as a percentage of network formation under control conditions, i.e., in the presence of vehicle alone.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts